NORTH
CHICAGO, Ill., Nov. 9, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the
4th Annual Wolfe Research Healthcare Conference on
Tuesday, November 15, 2022.
Rob Michael, vice chairman and
president, Jeffrey R. Stewart,
executive vice president, commercial operations, Scott Reents, senior vice president and chief
financial officer, and Neil
Gallagher, vice president development and chief medical
officer will present virtually at 10:30 a.m.
Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, and women's health, in
addition to products and services across our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us
at www.abbvie.com. Follow @abbvie on Twitter, Facebook,
Instagram, YouTube and LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-wolfe-research-healthcare-conference-301672371.html
SOURCE AbbVie